New software broadens market reach and enables surgeons to use Lantern Hip with their preferred surgical approach, including posterior-based approaches and DirectNew software broadens market reach and enables surgeons to use Lantern Hip with their preferred surgical approach, including posterior-based approaches and Direct

OrthAlign Expands Lantern® Hip Platform to Support Posterior-Based Surgical Approaches in Total Hip Arthroplasty

New software broadens market reach and enables surgeons to use Lantern Hip with their preferred surgical approach, including posterior-based approaches and Direct Anterior Approach (DAA)

IRVINE, Calif., Dec. 16, 2025 /PRNewswire/ — OrthAlign, Inc., a global leader in surgical navigation technologies, today announced the expansion of its Lantern® Hip platform to include support for posterior-based approaches in total hip arthroplasty (THA). This enhancement significantly broadens the platform’s clinical utility, enabling surgeons to choose Lantern Hip for any THA procedure, regardless of their clinical preference for patient position (“lateral” or “supine”).

With the majority of U.S. hip surgeons operating through posterior-based approaches, this new software meaningfully expands access to Lantern’s handheld, imageless navigation technology. Lantern Hip initially launched for the supine patient position in 2023 and will be fully commercially available for the lateral patient position by early 2026.

Lantern Hip is designed to deliver precise, real-time guidance that supports accurate implant positioning and reliable leg length restoration. For patients in the lateral position, the surgeon can personalize cup position in the coronal plane according to each patient’s unique anatomy, with live pelvic tracking that accounts for any pelvic movement during the procedure. Additionally for patients in the supine position, the surgeon can compare cup position across the Anterior Pelvic Plane (APP) and Functional Pelvic Plane (FPP), as well as measure change in offset.

The first clinical case using the new “lateral” workflow was successfully completed on December 16, 2025, by John McLaughlin, DO, Orthopedic Surgeon at the Cleveland Clinic.

“The addition of posterior-based approaches to Lantern Hip is an important step forward in supporting surgeon choice without compromising accuracy. In my first case, the system provided the same intuitive workflow and confidence in implant positioning that Lantern is known for. Having a compact, reliable navigation tool that adapts to my preferred surgical approach and implant enhances both efficiency in the OR and consistency for my patients,” said Dr. McLaughlin.

Lantern Hip is an accessible option for any hospital or ASC. Its capital-free model and portable design, paired with its clinical accuracy and precision, make it an attractive alternative to large-footprint robots. Its instrumentation is compatible with most implant systems and surgical approaches, empowering surgeons to choose the best implant and surgical plan for each patient without vendor-imposed restrictions.

“By accommodating posterior-based surgical approaches , OrthAlign now has the ability to support any surgeon performing total hip arthroplasty,” said Eric Timko, CEO of OrthAlign. “This expansion reflects our commitment to delivering high-value, user-friendly technologies that improve accuracy and accessibility for surgeons everywhere.”

OrthAlign, Inc. continues to advance surgeon-centric, handheld navigation technologies that reduce complexity and contain costs while enhancing accuracy in total joint arthroplasty. For more information, visit www.OrthAlign.com/LanternHip.

About OrthAlign, Inc.

OrthAlign is a medical device company with a focus on delivery practical, cutting edge technologies for orthopedic surgery. With a commitment to innovation and excellence, OrthAlign provides surgeons with user-friendly, cost-effective solutions to improve patient care in joint replacement.

Driven by the belief that everyone deserves exceptional healthcare, we are committed to making empowering technologies accessible to all.

For more information regarding OrthAlign, please visit www.orthalign.com.

Lantern is a registered trademark of OrthAlign, Inc.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/orthalign-expands-lantern-hip-platform-to-support-posterior-based-surgical-approaches-in-total-hip-arthroplasty-302643810.html

SOURCE OrthAlign

Market Opportunity
WorldAssets Logo
WorldAssets Price(INC)
$0.5908
$0.5908$0.5908
+2.10%
USD
WorldAssets (INC) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Born Again’ Season 3 Way Before Season 2

Born Again’ Season 3 Way Before Season 2

The post Born Again’ Season 3 Way Before Season 2 appeared on BitcoinEthereumNews.com. Daredevil Born Again Marvel MCU fans were thrilled that Charlie Cox’s Daredevil was being brought back to life after his unceremonious execution after his show’s Netflix run, where everything was transitioning to Disney Plus. Born Again felt like a moment that would never come, and when it did, it mostly satisfied fans, with few exceptions. Now, according to a new IGN interview with head of TV Brad Winderbaum, Marvel has greenlit Daredevil: Born Again for season 3, well before season 2 airs in March 2026. Originally, the plan was an 18-episode run across two seasons, but Marvel seems to have much larger plans for Matt Murdoch and his series. This is a combination of two things. First, the positive fan reception to season 1. While there were some hiccups here, where the middle of the season had parts of the previously canned version of the show they had to work around, the first and last few episodes were incredible, and that’s the team making all of season 2 and presumably season 3 going forward. So, that’s great news. Second, this is a move by Marvel to reduce the cost of its endless supply of Disney Plus shows by focusing on more “street level” content. MCU series have been all over the place in terms of their focus and their budgets, culminating in the ridiculous $212 million budget for six episodes of the VFX-heavy Secret Invasion, one of the worst things Marvel has ever produced. Now? The name of the game is lower costs. Agatha All Along was a prime example of this, one of the MCU’s cheapest projects ever but one of its best shows. Disney is investing deeper into the “Daredevil-verse” here, as season 2 of Born Again features Jessica Jones, who might be destined to return for her…
Share
BitcoinEthereumNews2025/09/19 02:29
Unleashing A New Era Of Seller Empowerment

Unleashing A New Era Of Seller Empowerment

The post Unleashing A New Era Of Seller Empowerment appeared on BitcoinEthereumNews.com. Amazon AI Agent: Unleashing A New Era Of Seller Empowerment Skip to content Home AI News Amazon AI Agent: Unleashing a New Era of Seller Empowerment Source: https://bitcoinworld.co.in/amazon-ai-seller-tools/
Share
BitcoinEthereumNews2025/09/18 00:10
CME Group to launch Solana and XRP futures options in October

CME Group to launch Solana and XRP futures options in October

The post CME Group to launch Solana and XRP futures options in October appeared on BitcoinEthereumNews.com. CME Group is preparing to launch options on SOL and XRP futures next month, giving traders new ways to manage exposure to the two assets.  The contracts are set to go live on October 13, pending regulatory approval, and will come in both standard and micro sizes with expiries offered daily, monthly and quarterly. The new listings mark a major step for CME, which first brought bitcoin futures to market in 2017 and added ether contracts in 2021. Solana and XRP futures have quickly gained traction since their debut earlier this year. CME says more than 540,000 Solana contracts (worth about $22.3 billion), and 370,000 XRP contracts (worth $16.2 billion), have already been traded. Both products hit record trading activity and open interest in August. Market makers including Cumberland and FalconX plan to support the new contracts, arguing that institutional investors want hedging tools beyond bitcoin and ether. CME’s move also highlights the growing demand for regulated ways to access a broader set of digital assets. The launch, which still needs the green light from regulators, follows the end of XRP’s years-long legal fight with the US Securities and Exchange Commission. A federal court ruling in 2023 found that institutional sales of XRP violated securities laws, but programmatic exchange sales did not. The case officially closed in August 2025 after Ripple agreed to pay a $125 million fine, removing one of the biggest uncertainties hanging over the token. This is a developing story. This article was generated with the assistance of AI and reviewed by editor Jeffrey Albus before publication. Get the news in your inbox. Explore Blockworks newsletters: Source: https://blockworks.co/news/cme-group-solana-xrp-futures
Share
BitcoinEthereumNews2025/09/17 23:55